278 related articles for article (PubMed ID: 35757427)
21. MicroRNA-218-5p relieves postmenopausal osteoporosis through promoting the osteoblast differentiation of bone marrow mesenchymal stem cells.
Kou J; Zheng X; Guo J; Liu Y; Liu X
J Cell Biochem; 2020 Feb; 121(2):1216-1226. PubMed ID: 31478244
[TBL] [Abstract][Full Text] [Related]
22. Relationship between serum intact parathyroid hormone concentrations and bone remodeling in type I osteoporosis: evidence that skeletal sensitivity is increased.
Kotowicz MA; Klee GG; Kao PC; O'Fallon WM; Hodgson SF; Cedel SL; Eriksen EF; Gonchoroff DG; Judd HL; Riggs BL
Osteoporos Int; 1990 Oct; 1(1):14-22. PubMed ID: 2133635
[TBL] [Abstract][Full Text] [Related]
23. Genetic susceptibility of postmenopausal osteoporosis on sulfide quinone reductase-like gene.
Cai X; Yi X; Zhang Y; Zhang D; Zhi L; Liu H
Osteoporos Int; 2018 Sep; 29(9):2041-2047. PubMed ID: 29855663
[TBL] [Abstract][Full Text] [Related]
24. Estrogens in rheumatoid arthritis; the immune system and bone.
Islander U; Jochems C; Lagerquist MK; Forsblad-d'Elia H; Carlsten H
Mol Cell Endocrinol; 2011 Mar; 335(1):14-29. PubMed ID: 20685609
[TBL] [Abstract][Full Text] [Related]
25. Evaluation of relationship between
Ma W; Chen K; Xiao W; Tang H; Wang S; Wang K
Artif Cells Nanomed Biotechnol; 2020 Dec; 48(1):818-823. PubMed ID: 32484721
[No Abstract] [Full Text] [Related]
26. Postmenopausal osteoporosis: a bioinformatics-integrated experimental study the pathogenesis.
Tian S; Song Y; Song J; Guo L; Peng M; Wu X; Qiao J; Bai M; Miao M
Biotechnol Genet Eng Rev; 2023 Jan; ():1-19. PubMed ID: 36641599
[TBL] [Abstract][Full Text] [Related]
27. Expression profile analysis of lncRNA in bone marrow mesenchymal stem cells exosomes of postmenopausal osteoporosis patients through microarray and bioinformatics analyses.
Wang J; Fu M; He S; Cai P; Xiang X; Fang L
Pathol Res Pract; 2022 Aug; 236():153985. PubMed ID: 35749916
[TBL] [Abstract][Full Text] [Related]
28. Feature selection approaches identify potential plasma metabolites in postmenopausal osteoporosis patients.
Wang J; Wang Y; Zeng Y; Huang D
Metabolomics; 2022 Nov; 18(11):86. PubMed ID: 36318345
[TBL] [Abstract][Full Text] [Related]
29. Overall adjustment acupuncture for postmenopausal osteoporosis (PMOP): a study protocol for a randomized sham-controlled trial.
Ren ZQ; Wang YF; Ao GF; Chen HX; Huang M; Lai MX; Zhao HD; Zhao R
Trials; 2020 Jun; 21(1):465. PubMed ID: 32493411
[TBL] [Abstract][Full Text] [Related]
30. Interleukin-17A Interweaves the Skeletal and Immune Systems.
Tang M; Lu L; Yu X
Front Immunol; 2020; 11():625034. PubMed ID: 33613566
[TBL] [Abstract][Full Text] [Related]
31. Effect of Primary Hypertension on Treatment Outcomes of Patients with Postmenopausal Osteoporosis: A 5 Year Follow Up Retrospective Study.
Yilmaz V; Umay E; Gundogdu I; Cakcı FA
High Blood Press Cardiovasc Prev; 2019 Feb; 26(1):61-67. PubMed ID: 30467637
[TBL] [Abstract][Full Text] [Related]
32. Postmenopausal bone loss in rheumatoid arthritis: effect of estrogens and androgens.
Sambrook P; Birmingham J; Champion D; Kelly P; Kempler S; Freund J; Eisman J
J Rheumatol; 1992 Mar; 19(3):357-61. PubMed ID: 1533677
[TBL] [Abstract][Full Text] [Related]
33. Learning from Monocyte-Macrophage Fusion and Multinucleation: Potential Therapeutic Targets for Osteoporosis and Rheumatoid Arthritis.
Gambari L; Grassi F; Roseti L; Grigolo B; Desando G
Int J Mol Sci; 2020 Aug; 21(17):. PubMed ID: 32825443
[TBL] [Abstract][Full Text] [Related]
34. Treatment of postmenopausal osteoporosis patients with teriparatide for 24 months reverts forming bone quality indices to premenopausal healthy control values.
Paschalis EP; Gamsjaeger S; Klaushofer K; Shane E; Cohen A; Stepan J; Pavo I; Eriksen EF; Taylor KA; Dempster DW
Bone; 2022 Sep; 162():116478. PubMed ID: 35779845
[TBL] [Abstract][Full Text] [Related]
35. Rheumatoid arthritis and Alzheimer's disease: genetic and epigenetic links in inflammatory regulation.
Ferraccioli G; Carbonella A; Gremese E; Alivernini S
Discov Med; 2012 Dec; 14(79):379-88. PubMed ID: 23272690
[TBL] [Abstract][Full Text] [Related]
36. Osteoporosis in experimental postmenopausal polyarthritis: the relative contributions of estrogen deficiency and inflammation.
Jochems C; Islander U; Erlandsson M; Verdrengh M; Ohlsson C; Carlsten H
Arthritis Res Ther; 2005; 7(4):R837-43. PubMed ID: 15987485
[TBL] [Abstract][Full Text] [Related]
37. Relationship of COL9A1 and SOX9 Genes with Genetic Susceptibility of Postmenopausal Osteoporosis.
Liu H; Zhao H; Lin H; Li Z; Xue H; Zhang Y; Lu J
Calcif Tissue Int; 2020 Mar; 106(3):248-255. PubMed ID: 31732751
[TBL] [Abstract][Full Text] [Related]
38. Role of the immune system in postmenopausal bone loss.
Weitzmann MN; Pacifici R
Curr Osteoporos Rep; 2005 Sep; 3(3):92-7. PubMed ID: 16131428
[TBL] [Abstract][Full Text] [Related]
39. Associations between ERα/β gene polymorphisms and osteoporosis susceptibility and bone mineral density in postmenopausal women: a systematic review and meta-analysis.
Zhu H; Jiang J; Wang Q; Zong J; Zhang L; Ma T; Xu Y; Zhang L
BMC Endocr Disord; 2018 Feb; 18(1):11. PubMed ID: 29458346
[TBL] [Abstract][Full Text] [Related]
40. [Bone demineralization and cytokines].
Orcel P; Cohen-Solal M; de Vernejoul MC; Kuntz D
Rev Rhum Mal Osteoartic; 1992 Sep; 59(6 Pt 2):16S-22S. PubMed ID: 1485126
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
